These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 6097235

  • 1. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G.
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [Abstract] [Full Text] [Related]

  • 2. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 3. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 01; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 4. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W, Patscheke H.
    Eicosanoids; 1989 Nov 01; 2(4):241-8. PubMed ID: 2517034
    [Abstract] [Full Text] [Related]

  • 5. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
    Gresele P, Deckmyn H, Arnout J, Lemmens J, Janssens W, Vermylen J.
    Lancet; 1984 May 05; 1(8384):991-4. PubMed ID: 6143969
    [Abstract] [Full Text] [Related]

  • 6. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV, Venton DL, Le Breton GC.
    J Pharmacol Exp Ther; 1984 Jan 05; 228(1):240-4. PubMed ID: 6319669
    [Abstract] [Full Text] [Related]

  • 7. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 05; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 8. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC, Bellan JA, Minkes RK, Beckerman RC, Wegmann MJ, Braquet P, McNamara DB, Kadowitz PJ.
    J Pharmacol Exp Ther; 1990 Dec 05; 255(3):1320-7. PubMed ID: 2175802
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 05; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 10. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 Mar 05; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 11. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
    Darius H, Lefer AM.
    Thromb Res; 1985 Dec 01; 40(5):663-75. PubMed ID: 2935972
    [Abstract] [Full Text] [Related]

  • 12. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A, Navran SS, Amin HM, Abdel-Aziz SA, Chang J, Sober DJ, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1985 Jan 01; 232(1):1-9. PubMed ID: 3855323
    [Abstract] [Full Text] [Related]

  • 13. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F, Lippton H, Kadowitz PJ.
    Thromb Haemost; 1981 Dec 23; 46(4):676-9. PubMed ID: 6800048
    [Abstract] [Full Text] [Related]

  • 14. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P, Arnout J, Deckmyn H, Huybrechts E, Pieters G, Vermylen J.
    J Clin Invest; 1987 Nov 23; 80(5):1435-45. PubMed ID: 2960694
    [Abstract] [Full Text] [Related]

  • 15. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep 23; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 16. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC, Schollmeyer P.
    Br J Pharmacol; 1989 Jul 23; 97(3):819-28. PubMed ID: 2503228
    [Abstract] [Full Text] [Related]

  • 17. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 23; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 18. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE, Burch RM, Saussy DL, Kochel PJ, Halushka PV.
    J Pharmacol Exp Ther; 1985 Dec 23; 235(3):729-34. PubMed ID: 3001275
    [Abstract] [Full Text] [Related]

  • 19. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
    di Minno G, Bertelé V, Bianchi L, Barbieri B, Cerletti C, Dejana E, de Gaetano G, Silver MJ.
    Thromb Haemost; 1981 Apr 30; 45(2):103-6. PubMed ID: 6266066
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM, Jones RL, Wilson NH, Marr CG.
    Br J Pharmacol; 1991 Mar 30; 102(3):607-14. PubMed ID: 1364826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.